Navigation Links
DelMar Pharmaceuticals Gives Quarterly Shareholder Update
Date:11/11/2013

re not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, clinical studies and future product commercialization; and, the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies. These and other factors are identified and described in more detail in our filings with the SEC, including, our current reports on Form 8-K. We do not undertake to update these forward-looking statements made by us.


'/>"/>
SOURCE DelMar Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. DelMar Pharmaceuticals Presents Data Supporting VAL-083 as a Potential Treatment for Three Chemotherapy Resistant Cancers
2. DelMar Pharma reviews glioblastoma clinical trials and new therapeutic development on CEOLIVE.TV
3. DelMar Pharmaceuticals and Guangxi Wuzhou Pharmaceuticals Establish Clinical Advisory Board in China
4. DelMar Pharmaceuticals To Present At The 15th Annual Rodman & Renshaw Global Investment Conference
5. DelMar Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
6. DelMar Pharmaceuticals Presents Additional Clinical Data from Ongoing Brain Cancer Study at ASCO
7. DelMar Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com June 6th
8. DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
9. DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013
10. DelMar Pharma Presents Encouraging Data From Ongoing Phase I/II GBM Clinical Trial With VAL-083
11. DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 3, 2015  MabVax Therapeutics (OTCQB: MBVX), a cancer diagnostic ... the Company,s President and CEO, will be presenting at the ... 9 – 12, 2015 at the Ritz Carlton in ... presentation is scheduled for Wednesday, March 11 th , at ... review on the Investor Relations section of the Company,s website ...
(Date:3/3/2015)... ATLANTA , March 3, 2015  3-D ... interventional radiology treatments to individual patient needs, with ... a specific size and shape. That,s according to ... of Interventional Radiology ,s Annual Scientific Meeting ... stents and filaments that were bioactive, giving these ...
(Date:3/3/2015)... , March 3, 2015 Although lung cancer ... world, there are only 18 drugs in the market ... and Avastin are nearing their patent expiry in 2015 ... market offers vast potential that drug manufacturers are vying ... of small cell lung cancer (SCLC) and non-small cell ...
Breaking Medicine Technology:3-D printing offers innovative method to deliver medication 23-D printing offers innovative method to deliver medication 33-D printing offers innovative method to deliver medication 4Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments 2Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments 3
(Date:3/3/2015)... Ark. (PRWEB) March 03, 2015 Jack ... announced that Mr. William A. Breukelman has been named ... recently completed development of the first fully integrated version ... uniquely capable of analyzing the three-dimensional motion of the ... then comparing the analysis at 15,300 points to the ...
(Date:3/3/2015)... Amboy, NJ (PRWEB) March 03, 2015 ... winners of “Picture of Health,” an interactive photo contest ... on Sunday, February 8, 2015. To raise awareness for ... visitors were encouraged to share their best health and ... appeared on Raritan Bay Medical Center’s website and Facebook ...
(Date:3/3/2015)... Indianapolis, IN (PRWEB) March 03, 2015 ... benefits advisory organization, is pleased to welcome The Gehring ... employee benefits consulting services for more than 20 years, ... class, employee benefits and risk management consulting firm that ... health insurance and risk management programs. , ...
(Date:3/3/2015)... 2015 The physicians at Diet Doc ... loss product that is being recommended by fast weight ... contains ingredients that help people lose weight while improving ... diet product thought to possess innovative solutions to the ... ingredients, all directed at targeting specific strategic points for ...
(Date:3/3/2015)... NJ (PRWEB) March 03, 2015 Getting to ... when our health and well-being are at stake. So when ... their ability to move about pain-free – it’s vital to ... of this crucial resource, according to Sridhar Yalamanchili, PT, MSPT, ... , A September 2014 nationwide survey by the ...
Breaking Medicine News(10 mins):Health News:William A. (Bill) Breukelman Named to CardioWise, Inc. Board of Directors 2Health News:William A. (Bill) Breukelman Named to CardioWise, Inc. Board of Directors 3Health News:Raritan Bay Medical Center Announces Winners of “Picture of Health” Photo Contest 2Health News:United Benefit Advisors Welcomes New Partner Firm The Gehring Group, Inc. 2Health News:United Benefit Advisors Welcomes New Partner Firm The Gehring Group, Inc. 3Health News:Diet Doc Discloses the Ingredients in their Powerful New Metabolism Boost for Controlled Appetite, Fast Weight Loss and Improved Mood 2Health News:Diet Doc Discloses the Ingredients in their Powerful New Metabolism Boost for Controlled Appetite, Fast Weight Loss and Improved Mood 3Health News:Diet Doc Discloses the Ingredients in their Powerful New Metabolism Boost for Controlled Appetite, Fast Weight Loss and Improved Mood 4Health News:Separating Fact from Fiction about Physical Therapy 2Health News:Separating Fact from Fiction about Physical Therapy 3
... Rutgers University have uncovered a new way to stimulate ... tumor cell clearance. Dipak Sarkar, professor in the ... Environmental and Biological Sciences and his research team have ... activate the immune cells to prevent cancer growth through ...
... , COLLEGE PARK, Md. - Revenue-driven surgery and poor ... a pair of logistical studies conducted by researchers at ... Business. The studies show a correlation between readmission ... time of discharge, suggesting that patients went home before ...
... a form of cancer where the plasma cells in the ... as well as predisposing patients to anemia, infection and kidney ... transplantation, commonly known as a stem cell transplant, is frequently ... Unfortunately, multiple myeloma continues to progress even after a transplant. ...
... Women who,ve witnessed or been the victims of violence may ... to new research. The study included 481 women being ... for a history of violence and current sexual risk-taking behaviors, ... unprotected sex. The researchers categorized the women as those ...
... -- ,Regions of the United States with lots of hospital ... have higher hospital readmission rates than regions with fewer beds ... Factors related to supply and demand had more of an ... or the quality of care received by patients the first ...
... Chicago Stritch School of Medicine student Jason Cuomo has ... Prize for Excellence in Neurology. The award recognizes excellence ... selected Cuomo to receive the prize, which is awarded ... The award is given to a student who exemplifies ...
Cached Medicine News:Health News:Rutgers team discovers novel approach to stimulate immune cells 2Health News:Rutgers team discovers novel approach to stimulate immune cells 3Health News:Revenue-driven surgery drives patients home too early 2Health News:Revenue-driven surgery drives patients home too early 3Health News:Study shows benefit of new maintenance therapy for multiple myeloma 2Health News: Women Exposed to Violence Might Have More Risky Sex 2Health News:Availability of Beds, Poverty Drive Costly Hospital Readmissions 2Health News:Availability of Beds, Poverty Drive Costly Hospital Readmissions 3
... New Durasphere EXP Injectable ... pyrolytic carbon-coated beads suspended in ... EXP Injectable Bulking Agent is ... adult women with stress urinary ...
... 650™ and 600M™ malleable penile prostheses offer ... with limited dexterity. These implants are always ... to position them in an erect or ... rigid enough for sexual intercourse and to ...
... AMS 700 Series is an advanced three-part inflatable ... abdomen, a pump placed in the scrotum and ... cavernosa. It closely simulates the look and performance ... innovative penile implant technology, the AMS 700 Series ...
Only Mentors reusable Alpine Leg Bag has patented Kraylex odor barrier, offset port options, and integrated loops providing total confidence and comfort....
Medicine Products: